BCAR1

Across TCGA pan-cancer cohorts, BCAR1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated BCAR1 data layer compared with 26 for mass-spec protein and 9 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher BCAR1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated BCAR1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, LUAD, and LSCC are the cancer types where BCAR1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Quartile	All	1.000	0.770	.003	44	view →
LUAD	DFS	Quartile	All	0.769	0.991	.013	8	view →
LSCC	DFS	Quartile	All	0.944	1.000	.019	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

BCAR1–UCEC (DFS)

Open the UCEC breakdown →